Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth differentiation factor 10 (GDF10) is a secreted protein belonging to the transforming growth factor-beta (TGF-β) superfamily, closely related to bone morphogenetic proteins. It is involved in diverse physiological processes including head and skeletal formation, inhibition of osteoblast and adipocyte differentiation, neural repair after injury, regulation of lipid metabolism, and suppression of tumor cell growth and metastasis. GDF10 binds TGF-beta receptors and modulates cellular responses via SMAD-dependent signaling. Its expression and functional activity are associated with disease states such as various cancers, post-stroke neural repair, and hepatic steatosis. GDF10 is multifunctional, and its dysregulation can have significant developmental and pathological consequences[1][2][3][4][5].
Not directly drug-targeted; when modulated, acts via TGF-beta receptor signaling and downstream SMAD activation or inhibition. Some compounds may alter GDF10 expression or signaling, contributing to their effects on neural recovery, cancer suppression, or metabolic regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth differentiation factor 10 (GDF10).